Equity (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2026 |
Dec. 31, 2025 |
| Equity [Line Items] |
|
|
| Schedule of Stock Option Activity |
|
Stock option activity for
the years ended December 31, 2025 and 2024 was as follows:
| |
|
Number of Options |
|
|
Weighted Average Exercise Price |
|
| Outstanding at January 1, 2024 |
|
|
56,880 |
|
|
$ |
149.03 |
|
| Granted |
|
|
10,265 |
|
|
$ |
4.13 |
|
| Expired |
|
|
(14,666 |
) |
|
$ |
(275.14 |
) |
| Outstanding at December 31, 2024 |
|
|
52,479 |
|
|
$ |
85.45 |
|
| Granted |
|
|
2,665 |
|
|
$ |
3.26 |
|
| Expired / cancelled / forfeited |
|
|
(13,975 |
) |
|
$ |
(87.50 |
) |
| Outstanding at December 31, 2025 |
|
|
41,169 |
|
|
$ |
79.43 |
|
| Options exercisable at December 31, 2025 |
|
|
41,169 |
|
|
$ |
79.43 |
|
|
| Schedule of Nonvested Stock Options Granted |
|
A summary of the status of the Company’s nonvested
stock options granted as of December 31, 2025 and changes during the years ended December 31, 2025 and 2024 is presented below:
| |
|
Number of Options |
|
|
Weighted Average Exercise Price |
|
| Nonvested at January 1, 2024 |
|
|
5,311 |
|
|
$ |
23.55 |
|
| Granted |
|
|
10,265 |
|
|
$ |
4.13 |
|
| Vested |
|
|
(9,633 |
) |
|
$ |
(10.31 |
) |
| Nonvested at December 31, 2024 |
|
|
5,943 |
|
|
$ |
11.54 |
|
| Granted |
|
|
2,665 |
|
|
$ |
3.26 |
|
| Cancelled |
|
|
(1,853 |
) |
|
$ |
(27.40 |
) |
| Vested |
|
|
(6,755 |
) |
|
$ |
(3.92 |
) |
| Nonvested at December 31, 2025 |
|
|
- |
|
|
$ |
- |
|
A summary of the status
of the Company’s nonvested stock warrants issued as of December 31, 2025 and changes during the years ended December 31, 2025 and
2024 was presented below:
| |
|
Number of Warrants |
|
|
Weighted Average Exercise Price |
|
| Nonvested at January 1, 2024 |
|
|
15,211 |
|
|
$ |
39.90 |
|
| Issued |
|
|
169,527 |
|
|
$ |
10.28 |
|
| Cancelled |
|
|
(23,288 |
) |
|
$ |
(32.85 |
) |
| Vested |
|
|
(81,450 |
) |
|
$ |
(12.10 |
) |
| Nonvested at December 31, 2024 |
|
|
80,000 |
|
|
$ |
7.50 |
|
| Vested |
|
|
(80,000 |
) |
|
$ |
(7.50 |
) |
| Nonvested at December 31, 2025 |
|
|
- |
|
|
$ |
- |
|
|
| Schedule of Stock Warrant Activity |
Stock
warrant activity for the three months ended March 31, 2026 was as follows:
| | |
Number of
Warrants | | |
Weighted Average
Exercise Price | |
| Outstanding at January 1, 2026 | |
| 95,746 | | |
$ | 24.06 | |
| Repricing adjustment | |
| 1,722,556 | | |
$ | 0.33 | |
| Granted | |
| 13,063,728 | | |
$ | 0.51 | |
| Exercised | |
| (1,733,571 | ) | |
$ | (0.33 | ) |
| Outstanding at March 31, 2026 | |
| 13,148,459 | | |
$ | 0.64 | |
| Exercisable at March 31, 2026 | |
| 84,731 | | |
$ | 20.40 | |
|
Stock warrant activity for
the years ended December 31, 2025 and 2024 was as follows:
| |
|
Number of
Warrants |
|
|
Weighted Average Exercise Price |
|
| Outstanding at January 1, 2024 |
|
|
43,035 |
|
|
$ |
75.53 |
|
| Issued |
|
|
169,527 |
|
|
$ |
10.28 |
|
| Cancelled (*) |
|
|
(23,288 |
) |
|
$ |
(32.85 |
) |
| Exercised |
|
|
(6,278 |
) |
|
$ |
(50.77 |
) |
| Outstanding at December 31, 2024 |
|
|
182,996 |
|
|
$ |
21.37 |
|
| Exercised |
|
|
(87,250 |
) |
|
$ |
(18.41 |
) |
| Outstanding and exercisable at December 31, 2025 |
|
|
95,746 |
|
|
$ |
24.06 |
|
| * | Second Warrant, which was issued on May 23, 2023, July 6, 2023, October 9, 2023, and March 7, 2024, was cancelled in June 2024. Second Warrant, which was issued on June 5, 2024, is still outstanding as of December 31, 2025 and 2024. |
|
| Schedule of Number of Pre-Funded Warrants Outstanding |
The
number of pre-funded warrants outstanding as of March 31, 2026 is as follows:
| Description | |
Number
Outstanding | | |
Weighted Average
Exercise Price | |
| Pre-funded warrants issued in December 2024 | |
| 150,000 | | |
$ | 0.01 | |
| Pre-funded warrants issued in February 2026 | |
| 5,882,353 | | |
$ | 0.0001 | |
| Outstanding at March 31, 2026 | |
| 6,032,353 | | |
$ | 0.0003 | |
|
The number of pre-funded
warrants outstanding as of December 31, 2025 is as follows:
| Description |
|
Number Outstanding |
|
|
Weighted Average Exercise Price |
|
| Pre-funded warrants issued in December 2024 |
|
|
150,000 |
|
|
$ |
0.01 |
|
| Pre-funded warrants issued in July 2025 |
|
|
354,300 |
|
|
$ |
0.0001 |
|
| Outstanding at December 31, 2025 |
|
|
504,300 |
|
|
$ |
0.0030 |
|
|
| Schedule of Pre-Funded Warrant Activity |
A
summary of pre-funded warrant activity during the three months ended March 31, 2026 is as follows:
| | |
Number of
Pre-Funded
Warrants | | |
Weighted Average
Exercise Price | |
| Outstanding at January 1, 2026 | |
| 504,300 | | |
$ | 0.0030 | |
| Pre-funded warrants granted | |
| 5,882,353 | | |
$ | 0.0001 | |
| Pre-funded warrants exercised | |
| (354,300 | ) | |
$ | (0.0001 | ) |
| Outstanding at March 31, 2026 | |
| 6,032,353 | | |
$ | 0.0003 | |
|
A summary of pre-funded
warrant activity during the years ended December 31, 2025 and 2024 is as follows:
| |
|
Number of Pre-Funded Warrants |
|
|
Weighted Average Exercise Price |
|
| Outstanding at January 1, 2024 |
|
|
- |
|
|
$ |
- |
|
| Pre-funded warrants issued |
|
|
150,000 |
|
|
$ |
0.01 |
|
| Outstanding at December 31, 2024 |
|
|
150,000 |
|
|
$ |
0.01 |
|
| Pre-funded warrants issued |
|
|
354,300 |
|
|
$ |
0.0001 |
|
| Outstanding at December 31, 2025 |
|
|
504,300 |
|
|
$ |
0.0030 |
|
|
| Options [Member] |
|
|
| Equity [Line Items] |
|
|
| Schedule of Common Stock Issuable Upon Exercise of Options Outstanding |
The
following table summarizes the shares of the Company’s common stock issuable upon exercise
of options outstanding at March 31, 2026:
| | Options Outstanding | | | Options Exercisable | | | | Range of Exercise Price | | | Number
Outstanding at
March 31,
2026 | | | Weighted
Average
Remaining
Contractual Life
(Years) | | | Weighted
Average
Exercise
Price | | | Number
Exercisable at
March 31,
2026 | | | Weighted
Average
Exercise
Price | | | $ | 2.93 – 31.20 | | | | 15,419 | | | | 2.57 | | | $ | 6.49 | | | | 15,419 | | | $ | 6.49 | | | $ | 48.75 – 123.00 | | | | 18,117 | | | | 0.98 | | | $ | 79.87 | | | | 18,117 | | | $ | 79.87 | | | $ | 154.50 – 228.00 | | | | 7,633 | | | | 3.75 | | | $ | 225.72 | | | | 7,633 | | | $ | 225.72 | | | $ | 2.93 – 228.00 | | | | 41,169 | | | | 2.09 | | | $ | 79.43 | | | | 41,169 | | | $ | 79.43 | |
|
The following table summarizes
the shares of the Company’s common stock issuable upon exercise of options outstanding at December 31, 2025:
| Options Outstanding | | Options Exercisable | | | Range of Exercise Price | | Number
Outstanding at
December 31,
2025 | | | Weighted
Average
Remaining
Contractual
Life (Years) | | | Weighted
Average
Exercise
Price | | | Number
Exercisable at
December 31,
2025 | | | Weighted
Average
Exercise
Price | | | $ | 2.93 – 31.20 | | | 15,419 | | | | 2.82 | | | $ | 6.49 | | | | 15,419 | | | $ | 6.49 | | | $ | 48.75 – 123.00 | | | 18,117 | | | | 1.23 | | | $ | 79.87 | | | | 18,117 | | | $ | 79.87 | | | $ | 154.50 – 228.00 | | | 7,633 | | | | 4.00 | | | $ | 225.72 | | | | 7,633 | | | $ | 225.72 | | | $ | 2.93 – 228.00 | | | 41,169 | | | | 2.34 | | | $ | 79.43 | | | | 41,169 | | | $ | 79.43 | |
|
| Warrants [Member] |
|
|
| Equity [Line Items] |
|
|
| Schedule of Common Stock Issuable Upon Exercise of Options Outstanding |
The
following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at March
31, 2026:
| Warrants Outstanding | | | Warrants Exercisable | | | Range of Exercise Price | | | Number
Outstanding at
March 31,
2026 | | | Weighted
Average
Remaining
Contractual Life
(Years) | | | Weighted
Average
Exercise
Price | | | Number Exercisable at
March 31, 2026 | | | Weighted
Average
Exercise
Price | | | $ | 0.37 – 0.64 | | | | 13,132,713 | | | | 3.20 | | | $ | 0.51 | | | | 68,985 | | | $ | 0.37 | | | $ | 9.75 – 37.50 | | | | 6,593 | | | | 3.10 | | | $ | 14.26 | | | | 6,593 | | | $ | 14.26 | | | $ | 67.50 | | | | 889 | | | | 2.18 | | | $ | 67.50 | | | | 889 | | | $ | 67.50 | | | $ | 187.50 | | | | 8,264 | | | | 1.06 | | | $ | 187.50 | | | | 8,264 | | | $ | 187.50 | | | $ | 0.37 – 187.50 | | | | 13,148,459 | | | | 3.20 | | | $ | 0.64 | | | | 84,731 | | | $ | 20.40 | |
|
The following table summarizes the shares of the
Company’s common stock issuable upon exercise of warrants outstanding at December 31, 2025:
| Warrants Outstanding | | Warrants Exercisable | | | Range of Exercise Price | | Number
Outstanding at
December 31,
2025 | | | Weighted Average Remaining Contractual Life (Years) | | | Weighted Average Exercise Price | | | Number
Exercisable
at December 31,
2025 | | | Weighted
Average
Exercise
Price | | | $ | 7.50 – 37.50 | | | 86,593 | | | | 3.42 | | | $ | 8.01 | | | | 86,593 | | | $ | 8.01 | | | $ | 67.50 | | | 889 | | | | 2.42 | | | $ | 67.50 | | | | 889 | | | $ | 67.50 | | | $ | 187.50 | | | 8,264 | | | | 1.30 | | | $ | 187.50 | | | | 8,264 | | | $ | 187.50 | | | $ | 7.50 – 187.50 | | | 95,746 | | | | 3.23 | | | $ | 24.06 | | | | 95,746 | | | $ | 24.06 | |
|